{"name":"MIG AG","permalink":"mig-ag","crunchbase_url":"http://www.crunchbase.com/financial-organization/mig-ag","homepage_url":"http://www.mig.ag","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"","description":"","email_address":"info@mig.ag","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Jul 07 19:57:45 UTC 2009","updated_at":"Mon Oct 05 09:29:41 UTC 2009","overview":"<p>MIG is a medium-sized businesses run by experienced venture capital firms. Their experiences give rise to a competence and security, which they gladly pass on to their portfolio of businesses. Meanwhile, they have contributed to the realization of more than twenty outstanding business ideas and entrepreneurial visions of the future a bit closer to the present.</p>","image":{"available_sizes":[[[150,50],"assets/images/resized/0006/1641/61641v1-max-150x150.png"],[[213,71],"assets/images/resized/0006/1641/61641v1-max-250x250.png"],[[213,71],"assets/images/resized/0006/1641/61641v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"Ismaninger StraÃŸe 102","address2":"81675 MÃ¼nchen","zip_code":"","city":"","state_code":null,"country_code":"DEU","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Capital Report Index","raised_amount":null,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":14,"company":{"name":"Sovicell","permalink":"sovicell","image":{"available_sizes":[[[117,93],"assets/images/resized/0006/4214/64214v1-max-150x150.jpg"],[[117,93],"assets/images/resized/0006/4214/64214v1-max-250x250.jpg"],[[117,93],"assets/images/resized/0006/4214/64214v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.protagen.de/customers_downloads/PR_Protagen_ENG_090803.pdf","source_description":"Protagen closes new Round of Financing for the Development of molecular Diagnostics for Prostate Cancer and Multiple Sclerosis","raised_amount":5330000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":3,"company":{"name":"Protagen","permalink":"protagen","image":{"available_sizes":[[[150,45],"assets/images/resized/0006/1127/61127v1-max-150x150.jpg"],[[173,53],"assets/images/resized/0006/1127/61127v1-max-250x250.jpg"],[[173,53],"assets/images/resized/0006/1127/61127v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.protagen.de/customers_downloads/PR_080115_eng.pdf","source_description":"Protagen raises â‚¬1 million to expand its protein biochips business unit","raised_amount":1000000,"raised_currency_code":"EUR","funded_year":2008,"funded_month":1,"funded_day":15,"company":{"name":"Protagen","permalink":"protagen","image":{"available_sizes":[[[150,45],"assets/images/resized/0006/1127/61127v1-max-150x150.jpg"],[[173,53],"assets/images/resized/0006/1127/61127v1-max-250x250.jpg"],[[173,53],"assets/images/resized/0006/1127/61127v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/pdc-biotech-gmbh-series-a-55m/","source_description":"PDC Biotech, GmbH: Series A $5.5M","raised_amount":5500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":1,"company":{"name":"PDC Biotech","permalink":"pdc-biotech","image":{"available_sizes":[[[150,36],"assets/images/resized/0007/5868/75868v1-max-150x150.jpg"],[[208,50],"assets/images/resized/0007/5868/75868v1-max-250x250.jpg"],[[208,50],"assets/images/resized/0007/5868/75868v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"","source_description":"Cap Funding Report","raised_amount":1190000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":1,"company":{"name":"Sovicell","permalink":"sovicell","image":{"available_sizes":[[[117,93],"assets/images/resized/0006/4214/64214v1-max-150x150.jpg"],[[117,93],"assets/images/resized/0006/4214/64214v1-max-250x250.jpg"],[[117,93],"assets/images/resized/0006/4214/64214v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/antisense-pharma-gmbh-series-e-175m/","source_description":"Antisense Pharma, GmbH: Series E $17.5M ","raised_amount":17500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":5,"company":{"name":"Antisense Pharma","permalink":"antisense-pharma","image":{"available_sizes":[[[107,33],"assets/images/resized/0008/2949/82949v2-max-150x150.png"],[[107,33],"assets/images/resized/0008/2949/82949v2-max-250x250.png"],[[107,33],"assets/images/resized/0008/2949/82949v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Cap Funding Report","raised_amount":6270000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":23,"company":{"name":"Biocrates Life Sciences","permalink":"biocrates-life-sciences","image":{"available_sizes":[[[150,42],"assets/images/resized/0008/4900/84900v1-max-150x150.jpg"],[[221,62],"assets/images/resized/0008/4900/84900v1-max-250x250.jpg"],[[221,62],"assets/images/resized/0008/4900/84900v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://protagen.de/customers_downloads/PR_060508_eng.pdf","source_description":"Protagen AG closes second round of financing with old and new investors","raised_amount":3300000,"raised_currency_code":"EUR","funded_year":2006,"funded_month":5,"funded_day":8,"company":{"name":"Protagen","permalink":"protagen","image":{"available_sizes":[[[150,45],"assets/images/resized/0006/1127/61127v1-max-150x150.jpg"],[[173,53],"assets/images/resized/0006/1127/61127v1-max-250x250.jpg"],[[173,53],"assets/images/resized/0006/1127/61127v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":338000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":16,"company":{"name":"IDENT Technology","permalink":"ident-technology","image":{"available_sizes":[[[150,20],"assets/images/resized/0009/3132/93132v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0009/3132/93132v1-max-250x250.jpg"],[[305,41],"assets/images/resized/0009/3132/93132v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.invest-iq.com/Arax-finances-Biocrates-Life-Sciences","source_description":"Arax Capital Leads Financing Round for Biocrates Life Systems","raised_amount":1600000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":25,"company":{"name":"Biocrates Life Sciences","permalink":"biocrates-life-sciences","image":{"available_sizes":[[[150,42],"assets/images/resized/0008/4900/84900v1-max-150x150.jpg"],[[221,62],"assets/images/resized/0008/4900/84900v1-max-250x250.jpg"],[[221,62],"assets/images/resized/0008/4900/84900v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/12/suppremol-closes-155m-series-c.html","source_description":"SuppreMol Closes â‚¬15.5M Series C Financing Round","raised_amount":15500000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":12,"funded_day":17,"company":{"name":"SuppreMol","permalink":"suppremol","image":{"available_sizes":[[[150,40],"assets/images/resized/0008/5052/85052v1-max-150x150.jpg"],[[195,53],"assets/images/resized/0008/5052/85052v1-max-250x250.jpg"],[[195,53],"assets/images/resized/0008/5052/85052v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}